Skip to content
by IQAC KIITKIIT Deemed to be University — Internal Quality Assurance Cell

Publication2021

MK2a inhibitor CMPD1 abrogates chikungunya virus infection by modulating actin remodeling pathway

The record

Type
Publication
Date
1 November 2021
Level
International — held abroad
Journal
Plos Pathogens
Volume
17
Issue
11
Published
1 November 2021
DOI
10.1371/journal.ppat.1009667
Scopus ID
85119930901
ISSN
15537366
Authors
14
Open access
Yes
Citations
15
International co-authorship
Yes
Co-author countries
IN, US

Classification

Every label below carries the reasoning it was assigned on, the confidence band it was assigned in, and what produced it. The rubric is published.

UN Sustainable Development Goals

  1. 3 Ensure healthy lives and promote well-being for all at all ages

    GoalPrimaryHigh confidenceJudged

    MK2a inhibitor CMPD1 abrogates chikungunya virus infection through actin remodeling pathway reducing viral progeny release and disease severity with enhanced survivability in animal models

    High confidence
    The subject matter is a strong and direct inference from the record type, the funding or organising body, or the programme context, even where the title alone is thin. Example: an ICMR-funded project against SDG 3, on the strength of the agency.
    Judged
    Judged against the published classification rubric, under the rubric and prompt versions recorded with the run that produced it.
    Produced by
    claude-haiku-4-5-20251001, under kortex-publication-v1

  2. 17.6 Enhance North-South, South-South and triangular cooperation on science, technology and innovation, and knowledge sharing

    TargetSecondaryHigh confidenceRule-derivedrule sdg17-structural-v1

    Structural signal: co-authorship outside India.

    Rule-derived
    Emitted by a deterministic rule from structural signals rather than judged from the record’s text. The rule carries a version, so rule-derived and judged labels stay separable.
    Produced by
    sdg17-structural-v1, under kortex-publication-v1

Viksit Bharat @2047

  1. vb-1.2 Health and well-being

    Sub-themePrimaryHigh confidenceJudged

    Targeted antiviral drug development directly addresses health outcomes in treatment of chikungunya virus epidemics

    Produced by
    claude-haiku-4-5-20251001, under kortex-publication-v1

Each label above carries the instrument and the version that produced it. How each classification is reached.

Evidence

Kortex hosts no documents. Evidence is an outbound link to the authority that holds it.

No outbound evidence link is recorded for this activity. The record below states which source it came from and when it was last read.

Provenance

Which source system this record came from, how many source rows were resolved into it, and when each was last read.

Source rows resolved into this record
1

Each record carries the date Kortex last read it from its source system. That is a freshness date and not a verification: Kortex records what its sources say and when it read them, and it does not check those statements against any external authority. No claim on this site is described as verified, because none is.

Citing this record

This URL is stable. A record’s permalink is frozen when it is published and is not regenerated if its title is later corrected.

KIIT Deemed to be University. “MK2a inhibitor CMPD1 abrogates chikungunya virus infection by modulating actin remodeling pathway”. Kortex.

Explore the full record